Selank 5mg

CLASSIFICATION Anxiolytic Peptide
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Beligas
WAREHOUSE International Warehouse 3
SUBSTANCE Selank ,

Unlock the potential of cutting-edge biotechnology with Selank, a revolutionary synthetic peptide known for its remarkable cognitive-enhancing and anxiolytic properties. Previously known as ?TP-7,? Selank is engineered to provide anti-anxiety benefits while enhancing learning and energy levels, all without the risk of addiction or significant side effects.

Developed through collaboration between the Institute of Molecular Genetics and the V.V. Zakusov Research Institute of Pharmacology in Russia, Selank is a compact molecule, smaller than most natural proteins, combining the sequence of tuftsin?a naturally occurring peptide found in antibodies?along with modifications to enhance its stability.

Research indicates that both tuftsin and Selank effectively reduce anxiety and elevate serotonin levels in animal studies, with Selank demonstrating enhanced efficacy. Approved in Russia for treating generalized anxiety disorder (GAD) and recognized as a nootropic, Selank is available in numerous countries as a "nutritional supplement," despite lacking FDA approval for medical use in the U.S.

While the exact mechanisms of Selank remain under investigation, it is believed to help stabilize enkephalins in the bloodstream?natural peptides that might alleviate stress. Some studies suggest that Selank interacts with GABA receptors, which are known for their calming effects. Research has shown that Selank treatment leads to increased activity in GABA-dependent inhibitory neurons, which may contribute to its sedative-like effects.

Additionally, Selank has been linked to elevated levels of BDNF (brain-derived neurotrophic factor), essential for cognitive functions like learning and memory. It also appears to influence neurotransmitters such as norepinephrine, dopamine, and serotonin, which are critical for motivation and focus. However, findings regarding its effects on these neurotransmitters are mixed, indicating that further research is necessary to clarify Selank's precise mechanisms.

In clinical trials, participants treated with Selank reported significant reductions in anxiety symptoms, particularly those with pre-existing anxiety disorders. A study involving patients with anxiety and phobias noted sustained improvements up to a week post-treatment. Furthermore, Selank has been shown to enhance the effects of phenazepam, an anti-anxiety medication, while mitigating undesirable side effects like drowsiness.

Animal studies support these findings, demonstrating that Selank effectively reduces anxiety in mice, especially in those with heightened anxiety levels. While the findings are promising, further research is essential to confirm Selank's safety and efficacy for human use. It is advisable for individuals with anxiety to consult a healthcare professional before considering Selank as a treatment option.

In a 30-day study, Selank was linked to the stabilization of memory traces in rats, although the methods of measurement remain unclear. Other animal studies suggest potential memory-preserving effects in monkeys, but reliable human data is still lacking, necessitating further exploration of its impact on cognitive function in healthy individuals.

Research has indicated that Selank may aid in restoring normal brain activity following toxin-induced damage in rats, highlighting its potential in neuroprotection.

Animal studies have shown Selank to reduce depressive symptoms, as evidenced by behavioral tests indicating increased mobility in stressful conditions.

Preliminary studies suggest that Selank can elevate antioxidant levels in stressed mice's livers, offering potential protective benefits.

In sedated cats, Selank was observed to temporarily lower blood pressure and increase cerebral blood flow, suggesting intriguing yet short-lived effects that warrant further investigation.

In studies involving rats undergoing alcohol withdrawal, Selank treatment was found to alleviate anxiety symptoms, showcasing its potential role in managing withdrawal effects.

Research has demonstrated that rats on a high-fat diet treated with Selank experienced significantly reduced weight gain, cholesterol levels, and blood glucose levels, indicating its potential in weight management strategies.

Initial studies in mice with breast cancer revealed that Selank slowed tumor growth and extended lifespan compared to untreated subjects. However, extensive research is required to validate these findings before considering clinical applications.

Selank has shown promise in modulating inflammatory responses and enhancing immune functions, although further studies are essential to elucidate its effectiveness.

Animal models have suggested that Selank can reduce stomach ulcer size, potentially through improved lymphatic flow, but more research is needed to confirm these findings in humans.

Selank has been linked to increased IL-6 levels in blood cells from individuals with depression, indicating potential immune system benefits. Additionally, some studies suggest it may stimulate the release of interferons, although its antiviral efficacy lacks conclusive evidence.